Screener
Abbott ABT Established Pharmaceuticals — Depreciation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
| (in millions) | Depreciation / Three Months Ended June 30, 2026 | Depreciation / Three Months Ended June 30, 2025 | Additions to Property and Equipment / Three Months Ended June 30, 2026 | Additions to Property and Equipment / Three Months Ended June 30, 2025 |
|---|---|---|---|---|
| Established Pharmaceuticals | $25 | $25 | $36 | $39 |
| Nutritional Products | 51 | 44 | 46 | 81 |
| Diagnostic Products | 165 | 135 | 157 | 166 |
| Medical Devices | 106 | 94 | 185 | 145 |
| Total Reportable Segments | 347 | 298 | 424 | 431 |
| Other | 55 | 59 | 75 | 62 |
| Total | $402 | $357 | $499 | $493 |
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's established pharmaceuticals — depreciation?
- Abbott (ABT) reported established pharmaceuticals — depreciation of $25M in Q2 2026.
- How has Abbott's established pharmaceuticals — depreciation changed year-over-year?
- Abbott's established pharmaceuticals — depreciation decreased by 0.0% year-over-year, from $25M to $25M.
- What is the long-term trend for Abbott's established pharmaceuticals — depreciation?
- Over 4 years (2021 to 2025), Abbott's established pharmaceuticals — depreciation has grown at a 1.8% compound annual growth rate (CAGR), from $94M to $101M.
- What does established pharmaceuticals — depreciation mean?
- This metric represents the systematic allocation of the cost of tangible assets, such as manufacturing equipment and facilities, over their useful lives within the established pharmaceuticals segment. It is a non-cash expense that reflects the wear and tear of the segment's physical infrastructure. It is a key component in calculating cash flow from operations.
Ask your AI about Abbott's established pharmaceuticals — depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude